These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7487691)

  • 1. Experience of once-daily aminoglycoside dosing using a target area under the concentration-time curve.
    Barclay ML; Duffull SB; Begg EJ; Buttimore RC
    Aust N Z J Med; 1995 Jun; 25(3):230-5. PubMed ID: 7487691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
    Lim AK; Mathanasenarajah G; Larmour I
    Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
    Koo J; Tight R; Rajkumar V; Hawa Z
    Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A suggested approach to once-daily aminoglycoside dosing.
    Begg EJ; Barclay ML; Duffull SB
    Br J Clin Pharmacol; 1995 Jun; 39(6):605-9. PubMed ID: 7654477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of serum aminoglycoside levels with once-daily dosing.
    Paterson DL; Robson JM; Wagener MM; Peters M
    Pathology; 1998 Aug; 30(3):289-94. PubMed ID: 9770195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous aminoglycoside usage and monitoring of patients with cystic fibrosis in Australia. What's new?
    Soulsby N; Bell S; Greville H; Doecke C
    Intern Med J; 2009 Aug; 39(8):527-31. PubMed ID: 19220547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.
    Rybak MJ; Abate BJ; Kang SL; Ruffing MJ; Lerner SA; Drusano GL
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1549-55. PubMed ID: 10390201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of children for whom routine monitoring of aminoglycoside serum concentrations is not cost effective.
    Massey KL; Hendeles L; Neims A
    J Pediatr; 1986 Nov; 109(5):897-901. PubMed ID: 3095524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy.
    Nezic L; Derungs A; Bruggisser M; Tschudin-Sutter S; Krähenbühl S; Haschke M
    Eur J Clin Pharmacol; 2014 Jul; 70(7):829-37. PubMed ID: 24756148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
    Prescott WA; Nagel JL
    Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.
    Barletta JF; Johnson SB; Nix DE; Nix LC; Erstad BL
    J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit.
    Langhendries JP; Battisti O; Bertrand JM; François A; Kalenga M; Darimont J; Scalais E; Wallemacq P
    Biol Neonate; 1998 Nov; 74(5):351-62. PubMed ID: 9742264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?
    Barclay ML; Kirkpatrick CM; Begg EJ
    Clin Pharmacokinet; 1999 Feb; 36(2):89-98. PubMed ID: 10092956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.
    Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB
    Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aminoglycoside panel: a new approach to monitoring aminoglycoside therapy.
    Gorsky JE; Latts JR
    Ther Drug Monit; 1983 Jun; 5(2):169-72. PubMed ID: 6879640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.
    Coulthard KP; Peckham DG; Conway SP; Smith CA; Bell J; Turnidge J
    J Cyst Fibros; 2007 Apr; 6(2):125-30. PubMed ID: 16829216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of aminoglycoside serum assays on clinical decisions and renal toxicity.
    Arroyo JC; Milligan WL; Davis J; Mitchell D
    South Med J; 1986 Mar; 79(3):272-6. PubMed ID: 3513326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.